A Prescription Blood Thinner Beat Aspirin at Preventing Recurrence of Blood Clots, Study Finds

A Canadian research team found low doses of the blood thinner rivaroxaban, marketed as Xarelto from Johnson& Johnson unit Janssen Pharmaceuticals, reduced the risk of blood clot recurrence by about 70% compared with aspirin, without increasing the risk of bleeding.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: FREE Source Type: news